Filing Details
- Accession Number:
- 0001185185-18-000642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-05 16:57:47
- Reporting Period:
- 2018-03-29
- Accepted Time:
- 2018-04-05 16:57:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1595248 | Genprex Inc. | GNPX | Pharmaceutical Preparations (2834) | 900772347 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735543 | Rodney John Varner | C/O Genprex, Inc. 100 Congress Avenue, Suite 2000 Austin TX 78701 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-29 | 10,000 | $5.00 | 544,735 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,614,152 | Indirect | by Laura Lane Biosciences, LLC |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | $0.96 | 2026-04-11 | 645,572 | 645,572 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2026-04-11 | 645,572 | 645,572 | Direct |
Footnotes
- Fully vested.
Billionaire Hedge Funds
